HOOKIPA Pharma (HOOK) began trading on the Nasdaq on Thur 18 Apr 19

HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immune-therapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform.

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 85
• Founded in 2011
• Headquartered in New York, New York
• http://www.hookipapharma.com

HOOKIPA Pharma IPO opened for trading at $14.30 after pricing downsized 6 mln share (from 6.67 mln shares) IPO at $14.00, the low-end of the expected $14.00-16.00 range